within Pharmacolibrary.Drugs.A_AlimentaryTractAndMetabolism.A03A_DrugsForFunctionalGastrointestinalDisorders.A03AC05_Tiropramide;

model Tiropramide
  extends Pharmacolibrary.Drugs.ATC.A.A03AC05;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>A03AC05</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Tiropramide is an antispasmodic agent belonging to the acylaminopropanol derivative class. It is primarily used for the treatment of gastrointestinal disorders involving smooth muscle spasms, such as irritable bowel syndrome and other functional gastrointestinal disorders. Tiropramide is not widely approved in many countries, and its use today is limited or discontinued in several regions.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for healthy adult individuals. No published clinical pharmacokinetic studies available.</p><h4>References</h4><ol><li><p>Arigoni, R, et al., &amp; Setnikar, I (1986). Pharmacokinetics of tiropramide after single doses in man. <i>Arzneimittel-Forschung</i> 36(4) 738–744. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/3718598/&quot;>https://pubmed.ncbi.nlm.nih.gov/3718598</a></p></li><li><p>Setnikar, I, et al., &amp; Zanolo, G (1988). Tiropramide and metabolites in blood and plasma after intravenous or peroral administration of 14C-tiropramide to the rat. <i>Arzneimittel-Forschung</i> 38(12) 1815–1819. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/3245854/&quot;>https://pubmed.ncbi.nlm.nih.gov/3245854</a></p></li><li><p>Kwon, OS, et al., &amp; Chung, YB (2003). Quantitative analysis of tiropramide in human blood by gas chromatography with nitrogen-phosphorus detector. <i>Archives of pharmacal research</i> 26(5) 416–420. DOI:<a href=&quot;https://doi.org/10.1007/BF02976700&quot;>10.1007/BF02976700</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/12785739/&quot;>https://pubmed.ncbi.nlm.nih.gov/12785739</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Tiropramide;
